Skip to content
HW210605 PREDiCT Tumour Models London logo

14 - 16 December, 2021
Digital Event, GMT

  • Home
  • About
    • About Event
    • About the PREDiCT Series
    • Content Hub
    • Testimonials
    • About Digital
    • FAQs
  • Programme
    • Full Event Guide
    • Speakers
    • Pre-Conference Workshop Day
    • Agenda
      • Day One
      • Day Two
  • Partnerships
    • Partnership Opportunities
    • Partners
    • Media Partners
    • PREDiCT Series Prospectus
  • Take Part
    • Register Interest
    • Contact us

Hera Biolabs

By | 3rd July 2019

Hera Biolabs, Inc., is an innovative pre-clinical CRO utilising cutting edge gene editing technologies to create novel in vivo models for oncology. Given our mission to accelerate cancer research and drug development, we focus upon rat models to deliver translationally relevant, high-quality results using proprietary technologies. Our first SRG model is the OncoRat®, which is uniquely suited for xenograft studies given its excellent tumour take-rates and ability to deliver masses 10x that of mouse models in half the time – all without the increased risk of genetic drift from multiple passages as observed in mice.

 

www.herabiolabs.com

OUR CONTACT DETAILS

T: +44 (0)20 3141 8700
E: info@hansonwade.com

VENUE DETAILS

Digital Event

ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

SEARCH

ORGANISED BY

HansonWade Logo

Terms & Conditions

Privacy Policy

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.